In the literature: December 2021.

Montagut, C; Gambardella, V; Cabeza-Segura, M; Fleitas, T; Cervantes, A.

Afiliação

Montagut C; Department of Medical Oncology, Hospital del Mar - IMIM, Barcelona, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
Gambardella V; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
Cabeza-Segura M; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
Fleitas T; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
Cervantes A; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain. Electronic address: andres.cervantes@uv.es.

ESMO Open ; 7(1): 100352, 2022 02.

Article em En | MEDLINE | ID: mdl-34920292

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article